about
Modeling the within-host dynamics of HIV infectionEvolutionary rescue: linking theory for conservation and medicineSalmonella enterica serovars Typhimurium and Typhi as model organisms: revealing paradigm of host-pathogen interactionsViral quasispecies evolutionContribution of HIV-1 genomes that do not integrate to the basic reproductive ratio of the virus.Adherence and drug resistance: predictions for therapy outcomeCounteracting Quasispecies Adaptability: Extinction of a Ribavirin-Resistant Virus Mutant by an Alternative Mutagenic TreatmentThe dynamics of human cytomegalovirus replication in vivoOptimal timing and duration of induction therapy for HIV-1 infectionPotential benefits of sequential inhibitor-mutagen treatments of RNA virus infectionsDrug-class specific impact of antivirals on the reproductive capacity of HIVAnalysis of the virus dynamics model reveals that early treatment of HCV infection may lead to the sustained virological responseNonheritable cellular variability accelerates the evolutionary processes of cancerExplaining the determinants of first phase HIV decay dynamics through the effects of stage-dependent drug actionWithin-host stochastic emergence dynamics of immune-escape mutantsEstimating HIV-1 fitness characteristics from cross-sectional genotype dataModeling the Effects of Morphine on Simian Immunodeficiency Virus DynamicsCancer in light of experimental evolutionPresence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapySynaptic transmission and the susceptibility of HIV infection to anti-viral drugsQuantifying the treatment efficacy of reverse transcriptase inhibitors: new analyses of clinical data based on within-host modeling.Limits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAARTStructure of the scientific community modelling the evolution of resistance.Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system.Evolutionary dynamics of HIV-induced subversion of the immune response.An accurate two-phase approximate solution to an acute viral infection modelConfidence from uncertainty--a multi-target drug screening method from robust control theory.Mapping complex traits as a dynamic system.Drug resistance in cancer: principles of emergence and prevention.Quantitative molecular analysis of virus expression and replication.Quantification of intrinsic residual viral replication in treated HIV-infected patients.Toward antiviral strategies that resist viral escapeAntibody responses during hepatitis B viral infection.Short-term measures of relative efficacy predict longer-term reductions in human immunodeficiency virus type 1 RNA levels following nelfinavir monotherapy.Non-linear mixed effects modeling of antiretroviral drug response after administration of lopinavir, atazanavir and efavirenz containing regimens to treatment-naïve HIV-1 infected patients.Immunological transitions in response to antigenic mutation during viral infection.A model of HIV-1 infection with two time delays: mathematical analysis and comparison with patient data.Stochastic interplay between mutation and recombination during the acquisition of drug resistance mutations in human immunodeficiency virus type 1Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
P2860
Q21245370-01078008-8FCB-4F49-8170-884EFDB75CACQ26862297-B8903EAE-B2BA-43B2-B815-F5CA4C03BBC2Q26996526-FEC5B1C6-CF1E-405F-880B-22D1FFAA11E8Q27013917-14E0B3AD-FFC1-4B43-8E4C-D67EF3B348FFQ27309008-E253891E-7045-4CA7-9AB9-8E879F695B9AQ27477742-97E41F78-4CA9-4484-B57E-CE533BD157EFQ27488361-2D650940-8448-4BE0-BF2E-3F53800B11F3Q28141142-7E12D68F-F6DE-45C4-871B-1F7E53CDD1D6Q28469250-2563D1EA-066B-45B0-A456-5867FAED101CQ28471847-CBE27D8B-07CE-44A1-8C3F-913249C97639Q28473451-0DA2974A-CED7-44FD-8AB3-9E4FBA544E86Q28481489-9B70BD95-C226-4806-B0F4-BF62EB947B16Q28482084-1668205D-065A-4D9C-9695-B2E625723C42Q28489076-5A5BB822-C0F5-43A4-ACFA-201A9146AFA1Q28544655-251AEBA9-8AE6-4E02-B500-C0D24CF4415DQ28544753-1E5FA01D-7141-432B-B204-FC2CFF5A1A7AQ28554352-E2C84CEC-75C6-466F-959F-5D456BF1379AQ28727500-AE46CFBF-1C93-4AC8-B742-FCB0AC74185AQ29615993-C11DD32F-D4AD-4FFA-A5EF-55923FCA0AECQ30541026-FC515A53-5BC4-49E3-86EC-1961E10BF611Q30892194-F625CD29-9A71-4213-AD4F-10541F045D60Q33296883-EBFC0D97-259F-4627-8CD0-1E8BC83F4B70Q33308734-98B52C30-839A-42ED-9237-A218B6CB4FABQ33313038-5CCC6CFE-EE59-468B-B898-26FD5DF34038Q33564308-2E4E21AE-8816-45ED-82E8-F44BF901B74CQ33683341-3666D91A-6F52-43B9-94E4-3ADB1A0AEEBCQ33739420-492C072C-350F-4840-9BA3-E660BB0D22D5Q33755473-1CD2A28C-3635-4EB0-95DC-9CA23CAF4B19Q33787936-0C8555B9-0850-4428-AE1C-A8612B89F7A3Q33892278-E61037A4-A477-49D5-9420-2112B785C8A6Q33931554-E737E2DA-485D-45E7-953F-FE344290380EQ33953001-398A6CFF-BC84-4302-B761-764A0E3B48E5Q33979280-885D7CA2-455B-433D-8CF6-70E71087E6D2Q33981600-4411523B-E5E5-43FF-861F-A2D8A612ED4FQ33982056-F0064027-A305-4A47-8169-1F58F3C4CB62Q34037355-E2C561D4-A13B-4830-8210-F62D4DD2ACD7Q34047035-19937746-9699-4E82-9AD4-E9BF5E001E0CQ34080406-AF505A35-DE07-440A-9B2B-E9FF5313D1B1Q34092679-B4F1E553-D104-4901-98A8-9ACDBBAD9876Q34299035-68E0C3A3-52B8-465D-B1B9-2CF4B359485A
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Virus dynamics and drug therapy
@ast
Virus dynamics and drug therapy
@en
type
label
Virus dynamics and drug therapy
@ast
Virus dynamics and drug therapy
@en
prefLabel
Virus dynamics and drug therapy
@ast
Virus dynamics and drug therapy
@en
P2860
P356
P1476
Virus dynamics and drug therapy
@en
P2093
P2860
P304
P356
10.1073/PNAS.94.13.6971
P407
P577
1997-06-01T00:00:00Z